ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,891Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 29

$733K Total Retail Price of All Prescriptions

Rank: 6 out of 29

665 Patients Receiving at Least One Drug in Part D
99%Patients 65 Years and Older
50% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 665 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 665 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 19,836 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LISINOPRIL 804 799 1 2
FUROSEMIDE 731 731 2 3
GABAPENTIN 689 687 3 10
AMLODIPINE BESYLATE 683 683 4 5
SIMVASTATIN 679 677 5 4
OMEPRAZOLE 642 642 6 8
POTASSIUM CHLORIDE 637 637 7 6
LEVOTHYROXINE SODIUM 621 621 8 1
CITALOPRAM HBR 589 589 9 11
MIRTAZAPINE 579 576 10 13
HYDROCODONE-ACETAMINOPHEN 523 519 S3 11 7
METOPROLOL SUCCINATE 431 431 12 16
PRAVASTATIN SODIUM 371 371 13 18
ALENDRONATE SODIUM 355 355 14 26
METOPROLOL TARTRATE 335 335 15 15
ATORVASTATIN CALCIUM 332 332 16 25
WARFARIN SODIUM 327 327 17 14
DONEPEZIL HCL 313 313 18 9
GLIMEPIRIDE 282 282 19 65
METFORMIN HCL 244 244 20 19
HYDROCHLOROTHIAZIDE 234 229 21 20
SERTRALINE HCL 219 219 22 17
POLYETHYLENE GLYCOL 3350 209 207 23 46
CLOPIDOGREL 207 207 24 33
LOSARTAN POTASSIUM 193 193 25 28
ISOSORBIDE MONONITRATE ER 185 185 26 44
DIGOXIN 173 173 27 34
NAMENDA 160 160 28 12
FENOFIBRATE 155 155 29 126
FLUTICASONE PROPIONATE 148 148 30 43
LISINOPRIL-HYDROCHLOROTHIAZIDE 145 145 31 64
BUPROPION HCL 138 138 32 135
TRAMADOL HCL 134 134 33 24
ALLOPURINOL 132 132 34 40
LABETALOL HCL 130 130 35 142
PLAVIX 125 125 36 51
TAMSULOSIN HCL 120 116 37 31
PANTOPRAZOLE SODIUM 111 111 38 59
SPIRONOLACTONE-HCTZ 110 110 39 122
QUETIAPINE FUMARATE 109 109 40 32
CRESTOR 107 107 41 62
NIFEDIPINE ER 105 105 42 95
PREDNISONE 103 103 43 41
TRIAMTERENE-HCTZ 102 102 44 48
LANTUS 102 102 44 39
ATENOLOL 102 102 44 23
PROPRANOLOL HCL 94 94 47 70
TRIAMCINOLONE ACETONIDE 93 93 48 88
KLOR-CON M20 91 91 49 57
CARVEDILOL 90 90 50 27
SUCRALFATE 81 81 51 91
BENAZEPRIL HCL 80 80 52 83
LOSARTAN-HYDROCHLOROTHIAZIDE 79 79 53 140
NORTRIPTYLINE HCL 79 77 53 73
DOXAZOSIN MESYLATE 78 78 55 123
LYRICA 77 74 56 67
ZOLPIDEM TARTRATE 74 74 57 30
INSULIN SYRINGE 69 69 58 130
RANITIDINE HCL 69 69 58 137
CLONIDINE HCL 65 65 60 53
VENLAFAXINE HCL ER 65 56 60 87
KLOR-CON M10 64 64 62 142
SPIRONOLACTONE 61 61 63 54
TRAZODONE HCL 61 61 63 22
DILTIAZEM ER 59 59 65 113
JANTOVEN 58 58 66 193
PHENYTOIN SODIUM EXTENDED 58 58 66 74
CILOSTAZOL 54 54 68 195
CIPROFLOXACIN HCL 53 52 69 66
LEVOFLOXACIN 51 51 70 60
AMIODARONE HCL 51 51 70 103
SEROQUEL 51 51 70 71
DILTIAZEM 24HR CD 51 51 70 109
KLOR-CON 10 51 51 70 202
SULFAMETHOXAZOLE-TRIMETHOPRIM 50 50 75 114
LIPITOR 50 50 75 158
SYNTHROID 50 50 75 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 25, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.